by Mrudula Kulkarni

3 minutes

Cosmo Pharmaceuticals Strengthens Management Team With New Head of Global Business Development

Cosmo Pharmaceuticals appoints Egle Gedrimaite as Head of Global Business Development, effective Oct 1.

Cosmo Pharmaceuticals Strengthens Management Team With New Head of Global Business Development

Cosmo Pharmaceuticals announces the appointment of Ms. Egle Gedrimaite as the new Head of Global Business Development, effective October 1, 2024. Egle Gedrimaite will report to Giovanni Di Napoli, CEO of Cosmo. As the company promotes resourceful development plans, Ms. Egle Gedrimaite is a relevant addition to the teams of Cosmo, with comprehensive knowledge in advancing global business operations and strategic market growth.

Egle Gedrimaite carries 15 years of experience as a business development director and alliance manager in the pharmaceutical, medical device, and nutraceutical industries. She has expertise in guiding successful businesses across both B2B and B2C sectors, driving the growth of established and newly launched products. 

Egle’s experience and cross-functional perspective qualify her to lead project development from start to end with all departments to achieve a successful outcome. She has prior experience working with Sofar and Alfasigma. She holds an International Communications and Communication Systems degree in International Relations from the Università per Stranieri di Perugia (Italy).

“Joining Cosmo Pharmaceuticals as Head of Global Business Development at this dynamic stage is an incredible opportunity. I am inspired by Cosmo’s vision and energy within the team, and I am eager to contribute to our shared goals of global leadership and industry innovation,” Egle Gedrimaite expressed her exhilaration.

“I would like our shareholders to feel Cosmo's positive energy and forward momentum. We are not just expanding our business but fostering a culture that values innovation and excellence at every level. With leaders like Egle on board, I am excited about the path ahead and our capacity to achieve remarkable growth, " said Cosmo CEO Giovanni Di Napoli.

Looking back at his initial three months as CEO, Giovanni shared his thoughts and continued, “My journey with Cosmo has been enriching, marked by a strong sense of purpose and a clear vision for the future. We are embracing a mindset of growth, innovation, and the empowerment of top talent across our organisation. Egle’s appointment as Head of Global Business Development is a testament to our commitment to these values. I am confident that her expertise will be pivotal as we expand our glo


Author Profile

Mrudula Kulkarni

Researcher Assistant

Comment your thoughts

Author Profile

Mrudula Kulkarni

Researcher Assistant

Ad
Advertisement

You may also like

Article
Teva Pharmaceutical Welcomes Matthew Shields as Executive Vice President of Global Operations

Mrudula Kulkarni